LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.8416
+0.0157 (1.90%)
Nov 19, 2025, 4:00 PM EST

LakeShore Biopharma Statistics

Total Valuation

LSBCF has a market cap or net worth of 34.68 million. The enterprise value is 87.92 million.

Market Cap34.68M
Enterprise Value 87.92M

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date Nov 14, 2025
Ex-Dividend Date n/a

Share Statistics

LSBCF has 41.21 million shares outstanding. The number of shares has increased by 89.95% in one year.

Current Share Class 41.21M
Shares Outstanding 41.21M
Shares Change (YoY) +89.95%
Shares Change (QoQ) +59.60%
Owned by Insiders (%) 87.55%
Owned by Institutions (%) 2.25%
Float 5.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.41
PB Ratio 0.50
P/TBV Ratio 0.59
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -6.38
EV / Sales 1.04
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -4.77

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.83.

Current Ratio 1.02
Quick Ratio 0.64
Debt / Equity 0.83
Debt / EBITDA n/a
Debt / FCF -3.10
Interest Coverage -3.15

Financial Efficiency

Return on equity (ROE) is -18.43% and return on invested capital (ROIC) is -3.22%.

Return on Equity (ROE) -18.43%
Return on Assets (ROA) -2.15%
Return on Invested Capital (ROIC) -3.22%
Return on Capital Employed (ROCE) -9.13%
Revenue Per Employee 147,899
Profits Per Employee -24,046
Employee Count573
Asset Turnover 0.43
Inventory Turnover 0.50

Taxes

Income Tax -130,486
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -65.37% in the last 52 weeks. The beta is 0.56, so LSBCF's price volatility has been lower than the market average.

Beta (5Y) 0.56
52-Week Price Change -65.37%
50-Day Moving Average 0.77
200-Day Moving Average 1.26
Relative Strength Index (RSI) 56.04
Average Volume (20 Days) 4,019

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.80

Income Statement

In the last 12 months, LSBCF had revenue of 84.75 million and -13.78 million in losses. Loss per share was -0.72.

Revenue84.75M
Gross Profit 69.89M
Operating Income -6.83M
Pretax Income -13.91M
Net Income -13.78M
EBITDA -1.78M
EBIT -6.83M
Loss Per Share -0.72
Full Income Statement

Balance Sheet

The company has 3.87 million in cash and 57.11 million in debt, giving a net cash position of -53.24 million or -1.29 per share.

Cash & Cash Equivalents 3.87M
Total Debt 57.11M
Net Cash -53.24M
Net Cash Per Share -1.29
Equity (Book Value) 68.87M
Book Value Per Share 3.32
Working Capital 2.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.67 million and capital expenditures -1.75 million, giving a free cash flow of -18.42 million.

Operating Cash Flow -16.67M
Capital Expenditures -1.75M
Free Cash Flow -18.42M
FCF Per Share -0.45
Full Cash Flow Statement

Margins

Gross margin is 82.47%, with operating and profit margins of -8.06% and -16.26%.

Gross Margin 82.47%
Operating Margin -8.06%
Pretax Margin -16.41%
Profit Margin -16.26%
EBITDA Margin -2.10%
EBIT Margin -8.06%
FCF Margin n/a

Dividends & Yields

LSBCF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -89.95%
Shareholder Yield -89.95%
Earnings Yield -39.72%
FCF Yield -53.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on October 4, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date Oct 4, 2024
Split Type Reverse
Split Ratio 0.1

Scores

LSBCF has an Altman Z-Score of -1.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.67
Piotroski F-Score 2